✦ LIBER ✦

Ecallantide: final HAE patient treated in the second phase III trial

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a 2-Stage, Phase 3 Pivotal Tr

✍ LEVY, R; MCNEIL, D; LI, H; HSU, F; HORN, P; ROBERTS, J 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Second-line chemotherapy with Capecitabi

✍ Ourania Katopodis; Aris Polyzos; Nikolaos Kentepozidis; Stylianos Giassas; Maria 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 335 KB

OC-0150 PREDICTIVE VALUE OF CAIX EXPRESS

✍ S. Rademakers; I. Hoogsteen; P. Rijken; C. Terhaard; P. Doornaert; J. Langendijk 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Health-related quality of life in patien

✍ Cella, D; Michaelson, M D; Bushmakin, A G; Cappelleri, J C; Charbonneau, C; Kim, 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 303 KB

Xyntha® is effective and safe in previou

✍ KATIA EVANS; ROBERT JANCO; CHANDRASEKHAR UDATA; AMANDA O’BRIEN; BROOKE HAYWARD; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Phase III randomized trial of sunitinib

✍ Carlos H. Barrios; Mei-Ching Liu; Soo Chin Lee; Laurence Vanlemmens; Jean-Marc F 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 289 KB